Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 161

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Inhibitors of alprazolam metabolism in vitro: effect of serotonin‐ reuptake‐inhibitor antidepressants, ketoconazole and quinidine.

Open access
von Moltke, LL, Greenblatt, DJ, Cotreau‐Bibbo, MM, Harmatz, JS, Shader, RI·1994·British Journal of Clinical Pharmacology

Abstract

1. The biotransformation of the triazolobenzodiazepine alprazolam (ALP) to its hydroxylated metabolites (4‐OH‐ALP and alpha‐OH‐ALP) was evaluated in human, monkey, rat, and mouse liver microsomes. 2. In all species 4‐OH‐ALP was the principal metabolite, accounting for 84% of clearance in human microsomes compared with 16% for alpha‐OH‐ALP. 3. Among the serotonin‐specific reuptake inhibitors fluoxetine (FLU) and sertraline (SERT), and their respective demethylated metabolites norfluoxetine (NOR) and desmethylsertraline (DES), NOR was the most potent inhibitor (mean Ki for 4‐OH‐ALP formation in humans: 11 microM), FLU the weakest (Ki = 83 microM), with SERT and DES falling in between (Ki = 24 and 20 microM). 4. The in vitro data predict 29% inhibition of ALP clearance at mean FLU and NOR plasma concentrations of 77 ng ml‐1 and 72 ng ml‐1, respectively, after correction for liver:water partition ratios in the range of 12‐14. The observed mean degree of inhibition in a previous in vivo study was 21%. 5. Ketoconazole was a potent inhibitor of ALP metabolism in vitro (Ki = 0.046 microM), suggesting that ALP hydroxylation is mediated by the cytochrome P450‐3A sub‐family. Quinidine was a weak inhibitor (Ki = 626 microM).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2125.1994.tb04317.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 161

Metadata

Authors
von Moltke, L., Greenblatt, D., Cotreau‐Bibbo, M., Harmatz, J., & Shader, R.
Venue
British Journal of Clinical Pharmacology
Publisher
Wiley
Published
1994-07
Volume
38
Issue
1
Pages
23-31
ISSN
  • 0306-5251 (ISSN-L)
  • 1365-2125
OpenAlex
W2016311788
Cited by
161
References
2
FWCI
17.94
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inhibitors of alprazolam metabolism in vitro: effect of serotonin‐ reuptake‐inhibitor antidepressants, ketoconazole and quinidine. https://app.cochat.ai/papers/10.1111/j.1365-2125.1994.tb04317.x
The paper
von Moltke, L., Greenblatt, D., Cotreau‐Bibbo, M., Harmatz, J., & Shader, R. (1994). Inhibitors of alprazolam metabolism in vitro: effect of serotonin‐ reuptake‐inhibitor antidepressants, ketoconazole and quinidine. British Journal of Clinical Pharmacology. https://doi.org/10.1111/j.1365-2125.1994.tb04317.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.